Literature DB >> 7882602

Renal hemodynamic response to stress is influenced by ACE-inhibitors.

R E Schmieder1, C Gatzka, H Schobel, H Schächinger, H Weihprecht.   

Abstract

Cardiovascular responses to new antihypertensive agents have been studied extensively under resting and stress conditions. However, the effects of antihypertensive agents on renal hemodynamics have only been investigated at rest. To test whether antihypertensive therapy leads to disparate renal hemodynamic effects during exposure to mental stress as opposed to resting conditions, we performed a double-blind, placebo-controlled crossover study. In 17 normotensive healthy men, glomerular filtration rate (GFR; inulin clearance) and renal plasma flow (RPF; para-aminohippuric acid clearance) were measured at rest and after a standardized mental stress test, with or without one week's treatment with a new, long-acting ACE-inhibitor cilazapril 2.5 mg/day. ACE-inhibition did not change resting blood pressure, RPF, GFR, or derived parameters, such as filtration fraction, renal vascular resistance and renal fraction of cardiac output. Mental stress caused an acute increase in GFR (p < 0.001) and filtration fraction with both treatments (0.001). However, the increase in GFR and filtration with mental stress was greater (p < 0.05) with cilazapril treatment than with placebo. Thus, renal hemodynamic responses to mental stress were influenced by ACE inhibitors. We conclude that the impact of antihypertensive agents on renal hemodynamics during stress cannot a priori be delineated from measurements at rest.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7882602

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  4 in total

1.  Effects of linagliptin on renal endothelial function in patients with type 2 diabetes: a randomised clinical trial.

Authors:  Christian Ott; Iris Kistner; Mirjam Keller; Stefanie Friedrich; Carsten Willam; Peter Bramlage; Roland E Schmieder
Journal:  Diabetologia       Date:  2016-09-01       Impact factor: 10.122

2.  Effects of the nitric oxide synthase inhibitor ronopterin (VAS203) on renal function in healthy volunteers.

Authors:  Christian Ott; Agnes Bosch; Nicole Winzer; Stephanie Friedrich; Reinhard Schinzel; Frank Tegtmeier; Roland E Schmieder
Journal:  Br J Clin Pharmacol       Date:  2019-02-28       Impact factor: 4.335

3.  Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargine.

Authors:  Christian Ott; Susanne Jung; Manuel Korn; Dennis Kannenkeril; Agnes Bosch; Julie Kolwelter; Kristina Striepe; Peter Bramlage; Mario Schiffer; Roland E Schmieder
Journal:  Cardiovasc Diabetol       Date:  2021-09-04       Impact factor: 9.951

4.  Association between serum 25-hydroxyvitamin D and the effects of Angiotensin II receptor blocker on renal function among African Americans: A post hoc analysis of a randomized placebo-controlled trial.

Authors:  Li Chen; Haidong Zhu; Gregory A Harshfield; Ying Huang; Yanbin Dong
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-18       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.